Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies.
Salabarria SM, Corti M, Coleman KE, Wichman MB, Berthy JA, D'Souza P, Tifft CJ, Herzog RW, Elder ME, Shoemaker LR, Leon-Astudillo C, Tavakkoli F, Kirn DH, Schwartz JD, Byrne BJ.
Salabarria SM, et al. Among authors: tavakkoli f.
J Clin Invest. 2024 Jan 2;134(1):e173510. doi: 10.1172/JCI173510.
J Clin Invest. 2024.
PMID: 37988172
Free PMC article.